Short timeline...
Ideally, a Breakthrough Therapy designation request should be received by FDA no later than the end-of-phase-2 meetings if any of the features of the designation are to be obtained. FDA will respond to Breakthrough Therapy designation requests within sixty days of receipt of the request.